Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis
Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis
About this item
Full title
Author / Creator
Publisher
BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
BMJ Publishing Group Ltd
More information
Scope and Contents
Contents
Glutamic acid decarboxylase autoantibody (GAD-65) catalyses glutamate conversion into γ-aminobutyric acid (GABA) in the central nervous system and in the pancreatic β cells. Antibodies targeting GAD-65 are of uncertain pathogenic significance and occur in stiff person syndrome, cerebellar ataxia, epilepsy, limbic encephalitis and combinations there...
Alternative Titles
Full title
Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_istex_primary_ark_67375_NVC_PX72G2JJ_8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_istex_primary_ark_67375_NVC_PX72G2JJ_8
Other Identifiers
E-ISSN
1757-790X
DOI
10.1136/bcr-2013-202314
